| P2093 | author name string | Kazuaki Negishi | |
| P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
| | Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 |
| | Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging | Q24676053 |
| | Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy | Q26775037 |
| | Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) | Q28378044 |
| | Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 |
| | 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q29620107 |
| | Diabetic cardiomyopathy: pathophysiology and clinical features | Q30457504 |
| | Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials | Q34196279 |
| | New type of cardiomyopathy associated with diabetic glomerulosclerosis | Q34205051 |
| | Results of a reevaluation of cardiovascular outcomes in the RECORD trial | Q34360464 |
| | Functional class in patients with heart failure is associated with the development of diabetes | Q34532622 |
| | Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | Q34540403 |
| | Metformin use and mortality in ambulatory patients with diabetes and heart failure | Q34614524 |
| | Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial | Q34660831 |
| | Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes | Q34673134 |
| | Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? | Q35904561 |
| | Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes | Q36050559 |
| | Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. | Q36172988 |
| | Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. | Q36625623 |
| | Pathophysiological effects of different risk factors for heart failure | Q36709180 |
| | Relation of regional echo amplitude to left ventricular function and the electrocardiogram in left ventricular hypertrophy | Q36751098 |
| | Diabetic cardiomyopathy revisited | Q36860318 |
| | Pioglitazone after Ischemic Stroke or Transient Ischemic Attack | Q36953272 |
| | Changes in diastolic dysfunction in diabetes mellitus over time | Q37237380 |
| | The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. | Q37425444 |
| | Diabetic cardiomyopathy: myth or reality? | Q38013390 |
| | Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. | Q38091002 |
| | Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage | Q38271210 |
| | Prediction of heart failure in patients with type 2 diabetes mellitus- a systematic review and meta-analysis | Q38357267 |
| | Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes | Q38427211 |
| | Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes | Q38729780 |
| | Dual-Imaging Stress Echocardiography for Prognostic Assessment of High-Risk Asymptomatic Patients with Diabetes Mellitus | Q38795508 |
| | Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. | Q38885540 |
| | Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes | Q39459893 |
| | Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin | Q39653389 |
| | Diabetes and cardiovascular disease. The Framingham study | Q41509493 |
| | Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. | Q42166803 |
| | Basal insulin and cardiovascular and other outcomes in dysglycemia | Q42507791 |
| | Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial | Q42684584 |
| | Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study | Q43514908 |
| | Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study | Q43619596 |
| | The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study | Q43636295 |
| | Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors | Q43720030 |
| | Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial | Q43722332 |
| | Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease | Q43742283 |
| | C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes | Q44155568 |
| | Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study | Q44292818 |
| | Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine | Q44541867 |
| | Role of diabetes in congestive heart failure: the Framingham study | Q44758886 |
| | Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link | Q44964081 |
| | Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials | Q45073420 |
| | Determinants of subclinical diabetic heart disease | Q45220590 |
| | Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study | Q45256257 |
| | Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. | Q45954011 |
| | Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes. | Q46244869 |
| | Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study | Q46423696 |
| | Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes | Q46811985 |
| | Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies | Q46822459 |
| | Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease | Q46927574 |
| | Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus | Q48831712 |
| | Impact of diabetes and hypertension on left ventricular longitudinal systolic function. | Q49050849 |
| | Does diabetes accelerate progression of calcific aortic stenosis? | Q51834836 |
| | Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus. | Q53154081 |
| | Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. | Q54017801 |
| | Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. | Q54567739 |
| | Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study) | Q57219237 |
| | Impact of diabetes on cardiac structure and function: the strong heart study | Q57219886 |
| | Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance | Q57604667 |
| | Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study) | Q57604699 |
| | Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction | Q57744320 |
| | Diastolic Stiffness of the Failing Diabetic Heart | Q58087772 |
| | Left Ventricular Chamber and Myocardial Systolic Function Reserve in Patients with Type 1 Diabetes Mellitus: Insight from Traditional and Doppler Tissue Imaging Echocardiography | Q60660791 |
| | Heart Failure Prevalence, Incidence, and Mortality in the Elderly With Diabetes | Q61784874 |
| | Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography | Q68393228 |
| | Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study | Q72168616 |
| | The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts | Q72852672 |
| | Echocardiographic detection of early diabetic myocardial disease | Q73029315 |
| | Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study | Q73782355 |
| | Significant increase in the prevalence of non-rheumatic aortic valve disease in patients with type 2 diabetes mellitus | Q79822561 |
| | Exercise-induced delayed onset of left ventricular early relaxation in association with coronary microcirculatory dysfunction in patients with diabetes mellitus | Q83144480 |
| | Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans | Q95381404 |
| P433 | issue | 1 | |
| P921 | main subject | echocardiography | Q216933 |
| | diabetic cardiomyopathy | Q5270132 |
| P304 | page(s) | 47-56 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | Cardiovascular diagnosis and therapy | Q26842243 |
| P1476 | title | Echocardiographic feature of diabetic cardiomyopathy: where are we now? | |
| P478 | volume | 8 | |